Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.42 - $0.72 $57,361 - $98,333
-136,574 Reduced 17.83%
629,612 $397,000
Q3 2023

Nov 13, 2023

BUY
$0.6 - $1.53 $91,357 - $232,962
152,263 Added 24.8%
766,186 $464,000
Q2 2023

Aug 11, 2023

SELL
$1.05 - $1.63 $25,164 - $39,064
-23,966 Reduced 3.76%
613,923 $694,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $253,616 - $576,977
211,347 Added 49.55%
637,889 $861,000
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $172,715 - $364,620
101,003 Added 31.03%
426,542 $793,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $262,139 - $1.19 Million
137,968 Added 73.56%
325,539 $801,000
Q2 2022

Aug 10, 2022

BUY
$2.13 - $9.01 $285,302 - $1.21 Million
133,945 Added 249.78%
187,571 $458,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $209,419 - $519,879
33,347 Added 164.44%
53,626 $427,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $73,720 - $143,780
-5,015 Reduced 19.83%
20,279 $310,000
Q3 2021

Nov 12, 2021

BUY
$24.31 - $33.6 $22,146 - $30,609
911 Added 3.74%
25,294 $719,000
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $143,703 - $222,523
5,508 Added 29.18%
24,383 $822,000
Q1 2021

May 11, 2021

SELL
$33.06 - $56.93 $163,514 - $281,575
-4,946 Reduced 20.76%
18,875 $721,000
Q4 2020

Feb 08, 2021

BUY
$39.09 - $57.4 $663,396 - $974,135
16,971 Added 247.75%
23,821 $996,000
Q3 2020

Nov 12, 2020

SELL
$28.43 - $44.67 $28,430 - $44,670
-1,000 Reduced 12.74%
6,850 $297,000
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $91,923 - $237,776
7,850 New
7,850 $238,000
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $135,587 - $488,042
-17,747 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$15.02 - $20.57 $24,032 - $32,912
-1,600 Reduced 8.27%
17,747 $286,000
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $78,416 - $114,400
4,160 Added 27.39%
19,347 $373,000
Q2 2019

Aug 08, 2019

BUY
$17.37 - $26.27 $263,798 - $398,962
15,187 New
15,187 $357,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.